Monoclonal
Monoclonal Antibody Reduces Asthma Attacks in Black and Latino Youth
[ad_1]
A National Institutes of Health (NIH) clinical trial found that mepolizumab, a monoclonal antibody, decreased asthma attacks by 27% among ...
NIH launches trial of monoclonal antibody to treat asthma in urban youth
[ad_1]
Study also will examine relationship of airway gene network activity to health outcomes.
Dupilumab is approved by the U.S. Food and Drug A...
A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges
[ad_1]
Case Reports
. 2022 Feb 28;14(2):e22721.
doi: 10.7759/cureus.22721.
eCollection 2022 Feb.
...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
